Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,100
Closed -$26K 442
2022
Q3
$26K Buy
+2,100
New +$36.8K 0.01% 237
2022
Q2
Sell
-191,385
Closed -$3.58M 496
2022
Q1
$4.13M Buy
191,385
+28,003
+17% +$944K 0.66% 37
2021
Q4
$7.05M Buy
163,382
+30,817
+23% +$1.52M 1.03% 25
2021
Q3
$6.97M Buy
132,565
+132,265
+44,088% +$8.01M 1.04% 25
2021
Q2
$20K Buy
+300
New +$22K ﹤0.01% 236

Other funds holding PATH

Burleson & Co's PATH Position: Q4 2022 in Review

Burleson & Co sold out of UiPath (PATH) in Q4 2022, closing a stake of 2,100 shares — an estimated $26K sold.

Burleson & Co first reported a position in PATH in Q2 2021 and held it in 5 quarters. The position peaked at $7.05M in Q4 2021. 336 funds tracked by Wall St. Rank hold PATH as of Q4 2022.

  • Burleson & Co reported no remaining UiPath position as of Q4 2022 after selling out during the quarter.
  • Burleson & Co sold 2,100 UiPath shares in Q4 2022, an estimated $26K.
  • Burleson & Co first reported a position in UiPath in Q2 2021 and held it in 5 quarters.
  • Burleson & Co's UiPath position peaked at $7.05M in Q4 2021.
  • 336 funds tracked by Wall St. Rank held UiPath as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.